1. An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literature

   • Sumanta Kumar Pal
   • Kathleen Blazer
   • George Somlo

   Review 26 May 2008 Pages: 1 - 5

   

2. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival

   • Andrea C. Bafford
   • Harold J. Burstein
   • Mehra Golshan

   Review 26 June 2008 Pages: 7 - 12

   

3. Role of melatonin in the epigenetic regulation of breast cancer

   • Ahmet Korkmaz
   • Emilio J. Sanchez-Barcelo
   • Russel J. Reiter

   Review 01 July 2008 Pages: 13 - 27

   

4. PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity

   • Jie Gao
   • Geng Kou
   • Yajun Guo

   Preclinical Study 15 May 2008 Pages: 29 - 41

   

5. Disruption of estrogen receptor α-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy

   • Wensheng Liu
   • Margot M. Ip
   • Gokul M. Das

   Preclinical Study 15 May 2008 Pages: 43 - 50

   

6. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives

   • A-Yong Cao
   • Juan Huang
   • Zhi-Ming Shao

   Preclinical Study 16 May 2008 Pages: 51 - 55

   

7. Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells

   • S. Hiscox
   • N. J. Jordan
   • R. I. Nicholson

   Preclinical Study 21 May 2008 Pages: 57 - 67

   

8. A common Greenlandic Inuit BRCA1 RING domain founder mutation

   • Thomas v. O. Hansen
   • Bent Ejlertsen
   • Finn C. Nielsen

   Preclinical Study 26 May 2008 Pages: 69 - 76

   

9. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome

   • Malini Harigopal
   • Jonas Heymann
   • David L. Rimm

   Preclinical Study 03 June 2008 Pages: 77 - 85

   

10. A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer

    • G. Fountzilas
    • U. Dafni
    • H. P. Kalofonos

    Clinical Trial 16 May 2008 Pages: 87 - 99

    

11. Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902

    • Johanna G. H. van Nes
    • Hein Putter
    • Cooperating Investigators of the EORTC

    Clinical Trial 18 May 2008 Pages: 101 - 113

    

12. Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer

    • Maura N. Dickler
    • Melody A. Cobleigh
    • Eric P. Winer

    Clinical Trial 22 May 2008 Pages: 115 - 121

13. The impact of sharing results of a randomized breast cancer clinical trial with study participants

    • Ann H. Partridge
    • A. C. Wolff
    • E. P. Winer

    Clinical Trial 10 June 2008 Pages: 123 - 129

    

14. Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer

    • Alessandra Gennari
    • Michele De Tursi
    • Stefano Iacobelli

    Clinical Trial 13 September 2008 Pages: 131 - 136

    

15. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures

    • Mostafa Saadat
    • Maryam Ansari-Lari

    Epidemiology 15 May 2008 Pages: 137 - 144

16. The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case–control and family analysis

    • Sharon E. Johnatty
    • Jonathan Beesley
    • The Kathleen Cuningham Consortium for Research in Familial Breast Cancer

    Epidemiology 15 May 2008 Pages: 145 - 150

17. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics

    • Lina Mu
    • Dionyssios Katsaros
    • Herbert Yu

    Epidemiology 15 May 2008 Pages: 151 - 162

    

18. Ethnic differences in the use of regular mammography: the multiethnic cohort

    • Quannetta T. Edwards
    • Arthur X. Li
    • Roberta McKean-Cowdin

    Epidemiology 21 May 2008 Pages: 163 - 170

    

19. Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition

    • Laura Baglietto
    • Dallas R. English
    • Graham G. Giles

    Epidemiology 29 May 2008 Pages: 171 - 179

20. Screening caused rising incidence rates of ductal carcinoma in situ of the breast

    • L. N. van Steenbergen
    • A. C. Voogd
    • L. V. van de Poll-Franse

    Epidemiology 31 May 2008 Pages: 181 - 183

    

21. No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study

    • Timothy R. Rebbeck
    • Antonis C. Antoniou
    • Douglas F. Easton

    Epidemiology 04 June 2008 Pages: 185 - 192

22. Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points

    • Bilal Majed
    • Thierry Moreau
    • Curie Institute Breast Cancer Group

    Epidemiology 12 June 2008 Pages: 193 - 203

23. Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?

    • S. J. Beyer
    • R. E. Jimenez
    • S. M. Jhiang

    Brief Report 26 May 2008 Pages: 205 - 212

    

24. Prepubertal physical activity up-regulates estrogen receptor β, BRCA1 and p53 mRNA expression in the rat mammary gland

    • M. Wang
    • B. Yu
    • L. Hilakivi-Clarke

    Brief Report 31 May 2008 Pages: 213 - 220